Person-specific cell therapy could potentially offer a cure as opposed to ongoing treatment, but it is also a disruptive technology that doesn't currently fit into traditional therapeutic manufacturing processes.
Angela Osborne
Advertisement
Dr Angela Osborne, eXmoor pharma concepts Ltd
Articles by Angela Osborne
Advertisement
Latest Updated Articles
- Overcoming manufacturing and financial challenges of personalized cell therapies
Published: April 1st 2010 | Updated:
Advertisement
Advertisement
